Upcoming Events
Search Result For "Solidtumor".
- Event Type
- Event Category
- Event Country
- Event Date
Event Type
Categories
Country
City
Date
Bispecifics and T-cell engagers are redefining the future of solid tumor treatment. With the landmark approvals of tarlatamab and ivonescimab, t...
Trailblazing Immunotherapies to Transform the Oncology and Autoimmune Landscapes
The Meeting Where Oncology Professionals Don’t Just Learn... They Debate
With new data and approvals...
With 2023 on track to see further growth in the immuno-oncology field, the availability of tools that offers drug developers and researchers advant...
Our core commitment centers on advancing R and D and Clinical Development strategies for TCR therapies, aiming to harness their immense potential i...
Prioritizing Back Translation from Bedside to Bench and Novel Targets With a whopping 7 approvals in the last two years, the field is alive with p...
Following the watershed approval of Iovances' Lifileucel, all eyes are now on TIL therapies as the up-and-coming major therapeutic avenue for solid...
The Complex Bioengineering for Cell Therapies Summit is the premier event for bioengineering experts. Explore cutting-edge technologies and platfor...
Celebrating a Decade of Uniting the NK Cell Therapy Community! As the NK community remains determined as ever to prove the advantages of NK cell...
2024 was pivotal for TCR therapies. Following the commercial approval for Adaptimmune's Tecelra, positive clinical readouts, and FIH trials from Im...
The T-cell engager (TCE) field has seen unprecedented growth, with eight approvals in the past two years—most recently tarlatamab—reinforcing i...
Fresh from the success of our Boston meeting, we're bringing the momentum to Europe for the very first time. This dedicated forum will unite lea...
Loading More...
